NCT01173536View on ClinicalTrials.gov

A Study to Investigate the Effect of GDC-0449 on the QT/QTc Interval in Healthy Female Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

61

Participants

Timeline

Start Date

August 25, 2010

Primary Completion Date

March 18, 2011

Study Completion Date

March 18, 2011

Conditions

Healthy Volunteer

Interventions

DRUG

GDC-0449

Oral repeating dose

DRUG

moxifloxacin

Oral single dose

DRUG

placebo

Oral repeating dose

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

lead

Genentech, Inc.

INDUSTRY